The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022

被引：50
作者：
Pang, Xiaojing [1 ]
Liu, Yang [1 ]
Li, Hua [1 ,2 ]
Chen, Lixia [1 ]
机构：
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang 110016, Peoples R China
[2] Fujian Univ Tradit Chinese Med, Inst Struct Pharmacol & TCM Chem Biol, Coll Pharm, Fuzhou 350122, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 257卷
基金：
中国国家自然科学基金;
关键词：
COVID-19; SARS-CoV-2; M pro inhibitors; Drug repurposing; Drug design; COVALENT INHIBITORS; GENOME SEQUENCE; ACHILLES-HEEL; CORONAVIRUS; DISCOVERY; EBSELEN; IDENTIFICATION; REPLICATION; DESIGN; 3C;
D O I：
10.1016/j.ejmech.2023.115491
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. The main protease (Mpro) of SARS-CoV-2 plays a central role in viral replication and transcription and represents an attractive drug target for fighting COVID-19. Many SARS-CoV-2 Mpro inhibitors have been reported, including covalent and noncovalent inhibitors. The SARS-CoV-2 Mpro inhibitor PF-07321332 (Nirmatrelvir) designed by Pfizer has been put on the market. This paper briefly introduces the structural characteristics of SARS-CoV-2 Mpro and summarizes the research progress of SARS-CoV-2 Mpro inhibitors from the aspects of drug repurposing and drug design. These information will provide a basis for the drug development of treating the infection of SARS-CoV-2 and even other coronaviruses in the future.
引用
收藏
页数：20
相关论文
共 50 条
  • [31] Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
    Ghahremanpour, Mohammad M.
    Tirado-Rives, Julian
    Deshmukh, Maya
    Ippolito, Joseph A.
    Zhang, Chun-Hui
    de Vaca, Israel Cabeza
    Liosi, Maria-Elena
    Anderson, Karen S.
    Jorgensen, William L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (12): : 2526 - 2533
  • [32] Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
    Hemmati, Seyed Ali
    Tabein, Saeid
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 142
  • [33] Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug
    Isgro, Camilla
    Sardanelli, Anna Maria
    Palese, Luigi Leonardo
    VIRUSES-BASEL, 2021, 13 (01):
  • [34] 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
    Forrestall, Katrina L.
    Burley, Darcy E.
    Cash, Meghan K.
    Pottie, Ian R.
    Darvesh, Sultan
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 335
  • [35] Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease
    Son Tung Ngo
    Ngoc Quynh Anh Pham
    Ly Thi Le
    Duc-Hung Pham
    Vu, Van V.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (12) : 5771 - 5780
  • [36] A Genetic Trap in Yeast for Inhibitors of SARS-CoV-2 Main Protease
    Alalam, Hanna
    Sigurdardottir, Sunniva
    Bourgard, Catarina
    Tiukova, Ievgeniia
    King, Ross D.
    Grotli, Morten
    Sunnerhagen, Per
    MSYSTEMS, 2021, 6 (06)
  • [37] Noncovalent Inhibitors of SARS-CoV-2 Main Protease: A Rescaffolding Attempt
    Krischuns, Tim
    Paisant, Sylvain
    Chen, Kuang-Yu
    Thirion, Laura N.
    Zettor, Agnes
    Chiaravalli, Jeanne
    Jacob, Yves
    Bellinzoni, Marco
    Naffakh, Nadia
    Janin, Yves L.
    SYNTHESIS-STUTTGART, 2025,
  • [38] De novo Design of SARS-CoV-2 Main Protease Inhibitors
    Fischer, Christian
    Veprek, Nynke A.
    Peitsinis, Zisis
    Ruhmann, Klaus-Peter
    Yang, Chao
    Spradlin, Jessica N.
    Dovala, Dustin
    Nomura, Daniel K.
    Zhang, Yingkai
    Trauner, Dirk
    SYNLETT, 2022, 33 (05) : 458 - 463
  • [39] Zinc thiotropolone combinations as inhibitors of the SARS-CoV-2 main protease
    DeLaney, Christopher
    Sheng, Yan
    Pectol, D. Chase
    Vantansever, Erol
    Zhang, Hanyuan
    Bhuvanesh, Nattamai
    Salas, Isaiah
    Liu, Wenshe R.
    Fierke, Carol F.
    Darensbourg, Marcetta Y.
    DALTON TRANSACTIONS, 2021, 50 (35) : 12226 - 12233
  • [40] Allosteric Hotspots in the Main Protease of SARS-CoV-2
    Stromich, Leonie
    Wu, Nan
    Barahona, Mauricio
    Yaliraki, Sophia N.
    JOURNAL OF MOLECULAR BIOLOGY, 2022, 434 (17)
12345